Rachel GuyAssociateSheppard, Mullin, Richter & Hampton LLPWebsitewww.sheppardmullin.comOrganization ProfileFull ProfileConnectEmail202-747-2188 Professional Biography Rachel Guy is an associate in the Antitrust and Competition Practice Group in the firm's Washington, D.C. office. More Legal and Business Bylines From Rachel Guy New DOJ Health Care Task Force Portends Continued Aggressive Antitrust Enforcement - (Posted On Thursday, May 23, 2024) California’s AB 3129: A New Hurdle for Private Equity Health Care Transactions on the Horizon? - (Posted On Sunday, April 21, 2024) Aggressive Procurement Collusion Enforcement Risk Remains High for 2024 - (Posted On Tuesday, February 13, 2024) The Wait is Over: DOJ and FTC Issue Final Merger Guidelines - (Posted On Wednesday, December 20, 2023) DOJ Announces Mergers & Acquisitions Safe Harbor Policy - (Posted On Wednesday, October 11, 2023) U.S. Healthcare Industry Remains Antitrust Enforcement Priority - (Posted On Monday, October 03, 2022) DOJ Sues to Block Merger Between Booz Allen Hamilton and EverWatch Based on Antitrust Concerns Relating to Single-Contract Market - (Posted On Friday, July 08, 2022) Government Contractors Facing Increased Antitrust Scrutiny - (Posted On Thursday, April 28, 2022) Current Legal Analysis China’s National Intellectual Property Administration Releases Statistical Data on Patent Licensing from 2019 – 2023 by: Aaron Wininger FTC Approves Final Order Against Seller of AI “Testimonial & Review” Service for Allegedly Providing Subscribers with Means to Generate Deceptive Reviews by: Richard B. Newman Cook County Employers: Time To Update Your Paid Leave Policies by: Alison B. Crane , Sarah J. Gasperini FTC Scrutinizing Healthcare Lead Generators and Marketers as Open Enrollment Begins by: Richard B. Newman Beltway Buzz, December 20, 2024 by: James J. Plunkett Final Regulations Released for Partnership Recourse Liabilities by: Kenneth C. Wang , Jared C. Kassan EPA Finalizes TSCA Risk Management Rules for PCE and TCE by: Mark N. Duvall , Ryan J. Carra The Legal and Economic Realities of Medicare Drug Pricing: Navigating Opportunities and Challenges by: Adam Herbst Upcoming Events Jan 8 2025 Whistleblower Protections: Navigating Health Care Employment & Labor Rights Jan 14 2025 What to Expect in Chemicals Policy and Regulation and on Capitol Hill in 2025 Jan 15 2025 Healthy AI Roundtable Chicago Jan 31 2025 Mass Actions: Bankruptcies, MDLs, Class Actions & Harrington v. Purdue Feb 26 2025 MCLE Triple Play Print
